What does DAC stand for in CJC-1295 DAC?

DAC stands for Drug Affinity Complex. It refers to a chemical modification added to the CJC-1295 peptide that allows it to bind to a blood protein called albumin. This binding protects the peptide from breaking down quickly, extending its active time in the body from minutes to several days — which is useful for research purposes.

How is CJC-1295 DAC different from regular CJC-1295?

The key difference is duration. Regular CJC-1295 (without DAC) has a shorter half-life and produces a more pulse-like release of growth hormone, similar to the body's natural rhythm. CJC-1295 DAC, with its albumin-binding tag, produces a longer, more sustained elevation of growth hormone and IGF-1. Researchers choose between them depending on the effect they want to study.

Is CJC-1295 DAC approved for human use?

No. CJC-1295 DAC is not approved by the FDA or other major regulatory agencies for use as a human therapeutic. It is classified as a research compound, meaning it is only intended for use in laboratory and scientific research settings. This article is educational only and does not constitute medical advice.

What is IGF-1 and why do researchers care about it?

IGF-1 stands for insulin-like growth factor 1. When growth hormone is released, the liver produces IGF-1 in response. IGF-1 is the molecule that actually delivers many of growth hormone's effects to muscle, bone, and other tissues — like promoting protein synthesis and cellular repair. Researchers often measure IGF-1 as a marker of growth hormone activity in the body.

CJC-1295 DAC: Research, Effects & Dosage Guide

What Exactly Is CJC-1295 DAC?

Let's start with the basics. Your body naturally makes a hormone called growth hormone-releasing hormone, or GHRH. Think of GHRH as a message your brain sends to your pituitary gland — a pea-sized organ at the base of your skull — telling it to release growth hormone (GH). Growth hormone does a lot of jobs: it helps build muscle, burn fat, repair tissue, and keep metabolism humming.

CJC-1295 DAC is a synthetic, lab-made version of GHRH. The "DAC" part stands for Drug Affinity Complex. That's a fancy way of saying the molecule has a special chemical tag attached to it. This tag allows it to bind to a protein in your blood called albumin. The result? Instead of breaking down in minutes like natural GHRH, CJC-1295 DAC can stay active in the body for days. Researchers call this an extended half-life.

Why Does a Longer Half-Life Matter?

Natural GHRH disappears from your bloodstream within a few minutes. That's fine for normal biology, but it makes it hard to study in a lab setting. CJC-1295 DAC solves that problem. Because it lingers longer, it produces a more sustained rise in growth hormone and a related hormone called IGF-1 (insulin-like growth factor 1). IGF-1 is the molecule that actually carries out many of growth hormone's effects in the body's tissues.

This extended action is what makes CJC-1295 DAC interesting to researchers — it gives them a reliable tool to study what happens when growth hormone signaling is turned up for a longer period.

What Are Scientists Researching?

Most of the research on CJC-1295 DAC is preclinical — meaning it's done in cell cultures or animal models — with a small number of early human studies. Here are the main areas scientists are exploring:

Body composition: Elevated growth hormone and IGF-1 are associated with increased lean muscle mass and reduced body fat. Researchers are looking at whether CJC-1295 DAC can reliably shift this balance.
Recovery and tissue repair: Growth hormone plays a role in healing. Some researchers are studying whether sustained GH elevation could speed up recovery from injury or exercise stress.
Metabolic health: GH influences how the body processes fats and sugars. Studies are examining whether this peptide could have implications for metabolic conditions, though this area is very preliminary.
Age-related GH decline: Growth hormone levels drop naturally as we age. Scientists are curious whether peptides like CJC-1295 DAC could help restore more youthful GH patterns in older adults.

What Does the Evidence Actually Show?

Here's where we need to be honest about where the science stands. Early human studies have confirmed that CJC-1295 DAC does what it's designed to do — it raises growth hormone and IGF-1 levels, and it does so for a prolonged period after a single dose. That part is fairly well established.

However, the clinical benefits — things like actual muscle gain, fat loss, or improved recovery in humans — are much less clear. Most of the exciting results come from animal studies, which don't always translate to humans. Large, long-term, controlled human trials are largely absent. Scientists also don't yet have a complete picture of the long-term safety profile.

In short: the mechanism is plausible, the early signals are interesting, but the evidence base is thin. This is a peptide firmly in the research phase.

Important Context: Research Use Only

CJC-1295 DAC is not approved by the FDA or equivalent agencies for therapeutic use in humans. It is used only in research settings. Anything you read about it — including this article — is for educational and informational purposes, not medical guidance. Always consult a qualified healthcare professional before considering any peptide compound.

Dosage: What Do Research Protocols Look Like?

Research protocols vary, and dosing in studies has differed based on the goals of the experiment. If you're looking for a structured overview of how CJC-1295 DAC has been used in research contexts, our CJC-1295 DAC dosage chart summarizes the commonly referenced research parameters in one place. You can also use our peptide calculator to explore how research doses are typically measured and prepared.

The Bottom Line

CJC-1295 DAC is a clever piece of molecular engineering. By extending the life of a natural hormone signal, it gives researchers a window into growth hormone biology that wasn't easy to study before. The science is genuinely interesting — but it's early, it's incomplete, and it's a long road from a promising lab result to a proven therapy. Watch this space, but keep expectations grounded in what the evidence actually supports right now.

CJC-1295 DAC: What It Is and What Research Is Exploring